Abstract Background: Chikungunya arthritis comprises overlapping pain-dominant, periarticular, inflammatory, and rheumatoid arthritis (RA)-like clinical phenotypes. Symptom duration alone does not capture this heterogeneity. Scope: This narrative review evaluates virological assays, antiviral and autoimmune serology, inflammatory mediators, imaging, and clinical outcomes. Human observations are distinguished from animal and cell-based mechanisms. Findings: Most biomarker evidence is exploratory.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile